Verònica Alba

609 total citations
21 papers, 309 citations indexed

About

Verònica Alba is a scholar working on Emergency Medicine, Virology and Infectious Diseases. According to data from OpenAlex, Verònica Alba has authored 21 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Emergency Medicine, 8 papers in Virology and 5 papers in Infectious Diseases. Recurrent topics in Verònica Alba's work include HIV-related health complications and treatments (9 papers), HIV Research and Treatment (8 papers) and Antibiotic Resistance in Bacteria (5 papers). Verònica Alba is often cited by papers focused on HIV-related health complications and treatments (9 papers), HIV Research and Treatment (8 papers) and Antibiotic Resistance in Bacteria (5 papers). Verònica Alba collaborates with scholars based in Spain, Canada and United States. Verònica Alba's co-authors include Jordi Vilà, Sara Martí, Javier Sánchez‐Céspedes, Consuelo Viladés, Francesc Vidal, Joaquim Peraire, Anna Rull, Esther Rodríguez‐Gallego, Manuel Leal and Ezequiel Ruíz-Mateos and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Verònica Alba

20 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verònica Alba Spain 12 118 83 79 75 70 21 309
Valeria Bellelli Italy 6 54 0.5× 56 0.7× 75 0.9× 43 0.6× 63 0.9× 9 273
Annie Fang United States 13 45 0.4× 15 0.2× 59 0.7× 12 0.2× 155 2.2× 29 394
Munjal Patel United States 7 39 0.3× 8 0.1× 45 0.6× 143 1.9× 60 0.9× 21 439
Emily Blodget United States 11 20 0.2× 37 0.4× 52 0.7× 15 0.2× 116 1.7× 23 304
Luke Utley United States 7 35 0.3× 4 0.0× 30 0.4× 111 1.5× 56 0.8× 10 235
Bryan T. Mogle United States 5 42 0.4× 7 0.1× 31 0.4× 28 0.4× 129 1.8× 9 219
Michael D. Spengler United States 10 9 0.1× 25 0.3× 97 1.2× 15 0.2× 46 0.7× 18 310
Bryan McGee United States 5 47 0.4× 11 0.1× 61 0.8× 20 0.3× 245 3.5× 12 366
Mohammed Janabi Tanzania 9 119 1.0× 28 0.3× 50 0.6× 5 0.1× 216 3.1× 15 412

Countries citing papers authored by Verònica Alba

Since Specialization
Citations

This map shows the geographic impact of Verònica Alba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verònica Alba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verònica Alba more than expected).

Fields of papers citing papers by Verònica Alba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verònica Alba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verònica Alba. The network helps show where Verònica Alba may publish in the future.

Co-authorship network of co-authors of Verònica Alba

This figure shows the co-authorship network connecting the top 25 collaborators of Verònica Alba. A scholar is included among the top collaborators of Verònica Alba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verònica Alba. Verònica Alba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazzari, Elisa de, Peré Domingo, Juan Tiraboschi, et al.. (2024). Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. Journal of Antimicrobial Chemotherapy. 79(5). 1133–1141. 1 indexed citations
2.
Rallón, Norma, Montserrat Olona, Salvador Resino, et al.. (2022). Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control. Frontiers in Immunology. 13. 822272–822272. 6 indexed citations
3.
Jorba, Rosa, Miguel López-Dupla, Peré Domingo, et al.. (2022). Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation. International Journal of Molecular Sciences. 23(15). 8071–8071. 2 indexed citations
4.
Abraham, Aswin, Sunita Ghosh, Verònica Alba, et al.. (2022). 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters can Predict Long-Term Outcome Following Trimodality Treatment for Oesophageal Cancer. Clinical Oncology. 35(3). 177–187.
5.
Abraham, Aswin, Kurian Joseph, Jennifer L. Spratlin, et al.. (2022). Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?. Clinical Oncology. 34(9). e369–e376. 5 indexed citations
6.
Viladés, Consuelo, Peré Domingo, Yolanda M. Pacheco, et al.. (2020). High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients. EBioMedicine. 62. 103077–103077. 16 indexed citations
7.
Joseph, Kurian, Verònica Alba, Larissa J. Vos, et al.. (2020). Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study. Radiotherapy and Oncology. 154. 93–100. 17 indexed citations
8.
Rodríguez‐Gallego, Esther, Joaquim Peraire, Miguel López-Dupla, et al.. (2019). IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status. Scientific Reports. 9(1). 15722–15722. 5 indexed citations
9.
Tarancón‐Díez, Laura, Esther Rodríguez‐Gallego, Anna Rull, et al.. (2019). Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection. EBioMedicine. 42. 86–96. 52 indexed citations
10.
Rodríguez‐Gallego, Esther, Josep Gómez, Peré Domingo, et al.. (2018). Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy. Atherosclerosis. 273. 28–36. 12 indexed citations
11.
Rodríguez‐Gallego, Esther, Laura Tarancón‐Díez, Felipe García, et al.. (2018). Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control. The Journal of Infectious Diseases. 219(6). 867–876. 23 indexed citations
12.
Rodríguez‐Gallego, Esther, Josep Gómez, Yolanda M. Pacheco, et al.. (2017). A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients. AIDS. 32(5). 565–573. 27 indexed citations
13.
López-Dupla, Miguel, Elsa Maymó‐Masip, Estebán Martínez, et al.. (2015). HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels. PLoS ONE. 10(12). e0144789–e0144789. 5 indexed citations
14.
Peraire, Joaquim, Miguel López-Dupla, Verònica Alba, et al.. (2015). HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma. Clinical Microbiology and Infection. 21(7). 711.e1–711.e8. 8 indexed citations
15.
Escoté, Xavier, Ana Megía, Miguel López-Dupla, et al.. (2011). A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy. HIV Medicine. 12(7). 428–437. 14 indexed citations
16.
Escoté, Xavier, Merce Miranda, Peré Domingo, et al.. (2011). Lipodystrophy and Insulin Resistance in Combination Antiretroviral Treated HIV-1–Infected Patients: Implication of Resistin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1). 16–23. 18 indexed citations
17.
Sánchez‐Céspedes, Javier, Sara Martí, Sara M. Soto, et al.. (2009). Two chromosomally located qnrB variants, qnrB6 and the new qnrB16, in Citrobacter spp. isolates causing bacteraemia. Clinical Microbiology and Infection. 15(12). 1132–1138. 16 indexed citations
18.
Alba, Verònica, Edit Urbán, M.Á. Domínguez, et al.. (2008). In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany. International Journal of Antimicrobial Agents. 33(3). 272–275. 20 indexed citations
19.
Martí, Sara, et al.. (2008). Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate. Diagnostic Microbiology and Infectious Disease. 61(4). 468–470. 10 indexed citations
20.
Martí, Sara, Javier Sánchez‐Céspedes, Verònica Alba, & Jordi Vilà. (2008). In vitro activity of doripenem against Acinetobacter baumannii clinical isolates. International Journal of Antimicrobial Agents. 33(2). 181–182. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026